Original Research
Published on 09 Jun 2023
A phase Ib trial of combined PKC and MEK inhibition with sotrastaurin and binimetinib in patients with metastatic uveal melanoma
Frontiers in Oncology
doi 10.3389/fonc.2022.975642
- 3,372 views
- 5 citations
Volumes
7,598 Publications
Clinical Trial
Published on 04 Apr 2023
Impact of the treatment crossover design on comparative efficacy in EMPOWER-Lung 1: Cemiplimab monotherapy as first-line treatment of advanced non-small cell lung cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.1081729
- 3,874 views
- 2 citations
Mini Review
Published on 21 Mar 2023
A review of research on the intersection between breast cancer and cardiovascular research in the Women’s Health Initiative (WHI)
Frontiers in Oncology
doi 10.3389/fonc.2022.1039246
- 4,190 views
- 8 citations
Original Research
Published on 13 Mar 2023
Analysis of factors influencing the distribution of 131-I in combined treatment of Licartin with transcatheter arterial chemoembolization in primary hepatic carcinoma
Frontiers in Oncology
doi 10.3389/fonc.2022.993948
- 1,906 views
- 1 citation
Original Research
Published on 09 Mar 2023
Extramural vascular invasion nomogram before radical resection of rectal cancer based on magnetic resonance imaging
Frontiers in Oncology
doi 10.3389/fonc.2022.1006377
- 1,637 views
Original Research
Published on 06 Mar 2023
The bioinformatic approach identifies PARM1 as a new potential prognostic factor in osteosarcoma
Frontiers in Oncology
doi 10.3389/fonc.2022.1059547
- 2,528 views
- 1 citation
Review
Published on 01 Mar 2023
The role of isoflavones in augmenting the effects of radiotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.800562
- 3,325 views
- 4 citations
Original Research
Published on 27 Feb 2023
TRIM37 interacts with PTEN to promote the growth of human T-cell acute lymphocytic leukemia cells through regulating PI3K/AKT pathway
Frontiers in Oncology
doi 10.3389/fonc.2022.1016725
- 2,416 views
- 1 citation
Correction
Published on 23 Feb 2023
Corrigendum: Murine models of acute myeloid leukemia
Frontiers in Oncology
doi 10.3389/fonc.2022.1089874
- 1,817 views
- 1 citation
Editorial
Published on 20 Feb 2023
Editorial: Biology and treatment of high-risk CLL
Frontiers in Oncology
doi 10.3389/fonc.2022.1109950
- 1,928 views
Original Research
Published on 20 Feb 2023
Association between sarcopenia and survival in patients with gynecologic cancer: A systematic review and meta-analysis
Frontiers in Oncology
doi 10.3389/fonc.2022.1037796
- 2,827 views
- 3 citations
Original Research
Published on 16 Feb 2023
Long-term effect of hospital volume on the postoperative prognosis of 158,618 patients with esophageal squamous cell carcinoma in China
Frontiers in Oncology
doi 10.3389/fonc.2022.1056086
- 2,515 views
- 1 citation
Review
Published on 16 Feb 2023
Fat necrosis: A consultant’s conundrum
Frontiers in Oncology
doi 10.3389/fonc.2022.926396
- 10,836 views
- 4 citations
Original Research
Published on 16 Feb 2023
Development of a hepatocellular carcinoma imaging database and structured imaging reports based on PACS, HIS, and repository
Frontiers in Oncology
doi 10.3389/fonc.2022.1033478
- 1,645 views
- 1 citation
Systematic Review
Published on 16 Feb 2023
Towards standardization of the parameters for opening the blood–brain barrier with focused ultrasound to treat glioblastoma multiforme: A systematic review of the devices, animal models, and therapeutic compounds used in rodent tumor models
Frontiers in Oncology
doi 10.3389/fonc.2022.1072780
- 3,942 views
- 7 citations
Review
Published on 16 Feb 2023
Oxygen switches: Refueling for cancer radiotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.1085432
- 2,759 views
- 2 citations